Scynex­is pulls vagi­nal in­fec­tion tablet from shelves, paus­es on­go­ing tri­als on the heels of con­t­a­m­i­na­tion risk con­cerns

Scynex­is pulled its vagi­nal in­fec­tion drug Brex­afemme (ibrex­a­fungerp) from the mar­ket and plac­ing a tem­po­rary hold on on­go­ing clin­i­cal tri­als due to con­t­a­m­i­na­tion risk is­sues …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.